High costs, low adherence: The GLP-1 challenge for managed care
Medicaid spending on GLP-1s has surged by 500% since 2019, with annual per-patient costs topping $17,000. Yet just one in three patients stay on these medications after a year. As demand soars, payer leaders face urgent questions about affordability, adherence, and equitable access.
To ensure the sustainable implementation of GLP-1s, managed care organizations must adopt innovative strategies, such as value-based contracting and comprehensive patient-engagement programs.
This report offers an evidence-based look at what GLP-1s mean for managed care — covering policy, pricing, and practical strategies for payer organizations.
What you'll learn:
To ensure the sustainable implementation of GLP-1s, managed care organizations must adopt innovative strategies, such as value-based contracting and comprehensive patient-engagement programs.
This report offers an evidence-based look at what GLP-1s mean for managed care — covering policy, pricing, and practical strategies for payer organizations.
What you'll learn:
- Key cost drivers and real-world adherence challenges
- Proven approaches to utilization management and risk mitigation
- Policy shifts and future trends shaping GLP-1 access and coverage
Please fill out the form to download the whitepaper.